News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Abbott Laboratories (ABT)' Kaletra HIV-Drug Patent Rejected in India, Allowing Cipla Ltd. Copies


1/4/2011 6:46:31 AM

Bloomberg -- Abbott Laboratories was refused copyright protection on its AIDS drug Kaletra by India’s patent office, allowing Cipla Ltd. and other generic-drug companies to continue selling copies.

Read at Pharmalot
Read at Bloomberg
Read at News Release
Read at Business Standard
Read at News Release
Read at News Release

comments powered by Disqus
Cipla Ltd.
Abbott
 
 
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES